Bluebird Bio Inc (BLUE) Return on Investment ROI from the first quarter of 2025 to first quarter of 2024 and for the year 2025, average high and low, overall ranking from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bluebird Bio Inc   (NASDAQ: BLUE)


Bluebird Bio Inc's ROI from its first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Bluebird Bio Inc's ROI in the first quarter of 2025?
Bluebird Bio Inc achieved a return on average invested assets (ROI) of 104.07 % in its first quarter of 2025, this is above BLUE's average return on investment of -32.07%.
Bluebird Bio Inc invested over the 12 months ending in its first quarter of 2025 $134 million

Despite the deterioration in its net income, company has improved ROI compared to the fourth quarter of 2024.

Within the Healthcare sector 22 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2025 quarter, so far to 87, from total ROI ranking in the fourth quarter of 2024 at 2194.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Investment Change TTM -53.18 % -18.63 % 44.35 % 41.32 % 49.82 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -19 139 169 247 338
Return On Investment (TTM) - -0.03 % -5.47 % -35.72 % -58.04 %
BLUE's Overall Ranking # 87 # 2194 # 2467 # 2688 # 0
Seq. Investment Change TTM -39.98 % -23.89 % 1.39 % 1.08 % 4.32 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 139 0 -16 -103 -166

BLUE Company Profile >> Back to BLUE Roi Comparisons >> See Annual BLUE Return On Investment



Return On Investment BLUE's Ranking
Within: No.
Industry # 4
Sector # 23
Overall # 87

Return On Investment Statistics
High Average Low
52.44 %
-32.07 %
-118.46 %
(Mar 31 2025)   (Sep 30 2022)







Financial Statements
Bluebird Bio Inc's I. Quarter Investments $ -19 Millions BLUE's Balance sheet
Bluebird Bio Inc's I. Quarter Income $ 0 Millions Quarterly BLUE's Income Statement
BLUE's Income by Division See BLUE's Income by Division


BLUE Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 139 419 196 374 1,578
Y / Y Investment Growth -66.88 % 113.33 % -47.53 % -76.27 % 4.91 %
Net Income in Millions 0 0 -267 -819 -619
Y / Y Net Income Growth - - - - -
Annual Return On Investment -0.05 % 0.03 % -135.71 % -218.87 % -39.22 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BLUE's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BLUE's Competitors
Subscribers only: Roi for Bluebird Bio Inc's Suppliers
Subscribers only: Return On Investment for BLUE's Customers

Other Ratios
BLUE's Roa BLUE's Inventory Turnover Ratio BLUE's Growth Rates BLUE's Dividend Statistics
BLUE's Profitability Ratios BLUE's Asset Turnover Ratio BLUE's Dividend Growth
BLUE's Roe BLUE's Valuation Ratios BLUE's Financial Strength Ratios BLUE's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2025, within Healthcare Sector ROI
Interpace Biosciences Inc   213.95 %
Cytomx Therapeutics Inc   139.64 %
Camp4 Therapeutics Corporation  136.24 %
Alumis inc   113.83 %
Stablecoin Development Corporation  110.75 %
Earth Science Tech Inc   100.58 %
Oak Woods Acquisition Corp  93.88 %
Avalo Therapeutics Inc   88.86 %
Tao Synergies Inc   78.95 %
Synlogic Inc   73.65 %
Novavax inc   71.31 %
Medinotec Inc   60.77 %
Exelixis Inc   59.41 %
Gridai Technologies Corp  58.38 %
Longduoduo Co Ltd  56.87 %
Adma Biologics Inc   53.77 %
Bluebird Bio Inc   52.44 %
Seres Therapeutics Inc   52.22 %
Pharmacyte Biotech Inc   48.77 %
Agios Pharmaceuticals Inc   48.46 %
Dariohealth Corp   44.97 %
Sbc Medical Group Holdings Incorporated  41.74 %
Champions Oncology Inc   41.16 %
Ptc Therapeutics inc   40.79 %
Rigel Pharmaceuticals Inc  39.96 %
Mettler toledo International Inc   39.75 %
Idexx Laboratories Inc  39.40 %
Edwards Lifesciences Corporation  38.53 %
Puma Biotechnology Inc   34.10 %
Hims and Hers Health Inc   34.04 %

Date modified: 2026-09-26T07:02:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.